REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Syngen Biotech Co., Ltd. (Taiwan, China)

Main Activities: Chemical Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Syngen Biotech Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Syngen Biotech Co., Ltd. is a biotech company that specializes in strain identification, micro-organism fermentation, recovery and purification. The company was founded in 1999 and is headquartered in Tainan City, Taiwan.

Headquarters
Building A, No.154,Kai-Yuan Road, Hsin-Ying(730)
Tainan City; Tainan City;

Contact Details: Purchase the Syngen Biotech Co., Ltd. report to view the information.

Website: http://www.syngen.com.tw

Basic Information
Total Employees:
Purchase the Syngen Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Syngen Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Syngen Biotech Co., Ltd. report to view the information.
Incorporation Date:
April 28, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
46.68%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Syngen Biotech Internationl Sdn. Bhd. (Malaysia)
100%
展碩生技醫藥股份有限公司
100%
Company Performance
Financial values in the chart are available after Syngen Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
8.74%▲
Total operating revenue
8.58%▲
Operating profit (EBIT)
-9.14%▼
EBITDA
-13.33%▼
Net Profit (Loss) for the Period
-25.87%▼
Total assets
2.44%▲
Total equity
5.29%▲
Operating Profit Margin (ROS)
-2.87%▼
Net Profit Margin
-5.2%▼
Return on Equity (ROE)
-2.18%▼
Debt to Equity Ratio
13.08%▲
Quick Ratio
0.28%▲
Cash Ratio
0.11%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo